Immunohistochemical analysis of the proliferation marker KI67 showed that PML silencing impaired cancer cell proliferation in both models (Fig. 3E,F), although data in A498 tumors were not statistically significant (Fig. 3F), possibly because control tumors showed vast necrotic areas and reduced KI67 positivity at the experimental endpoint. Here, MKI67 is linked to cancer.